CD19 and acute lymphoblastic leukemia: Single cell expression analysis from a B-ALL patient before and after CAR treatment identified the presence of CD19 negative B-ALL clones previous to the CAR-T-cell treatment, suggesting selective amplification of CD19 negative clones already present in the patient [50].